Necrotizing fasciitis with no mortality or limb loss

American Surgeon

Volumn 74, Issue 9, 2008, Pages 809-812

  Martin, Deborah A ^a,b   Nanci, Gabriella N ^a   Marlowe, Steven I ^a   Larsen, Alan N ^a  

^a NORTHSIDE HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CLINDAMYCIN; GENTAMICIN; METRONIDAZOLE; PENICILLIN G; RIFAMPICIN; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEBRIDEMENT; DISEASE COURSE; DRUG USE; FEMALE; HUMAN; MALE; MUSCLE NECROSIS; NECROTIZING FASCIITIS; OXYGEN THERAPY; VACUUM ASSISTED CLOSURE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; COHORT STUDIES; COMBINED MODALITY THERAPY; DEBRIDEMENT; FASCIITIS, NECROTIZING; FEMALE; HUMANS; MALE; MIDDLE AGED; NEGATIVE-PRESSURE WOUND THERAPY; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 66449109974     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Majeski JA, Alexander JW. Early diagnosis, nutritional support, and immediate extensive debridement improve survival in necrotizing fasciitis. Am J Surg 1983;145:784-787
2. Sudavsky LA, Laschinger JC, Coppa GF, Spencer FC. Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann Surg 1987;206:661. (Pubitemid 18012148)
3. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med 1996;334:240. (Pubitemid 26030675)
4. Hasham S, Matteucci P, Stanley PRW, Hart NB. Necrotising fasciitis. BMJ 2005;330:830. (Pubitemid 40529805)
5. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989;321:1. (Pubitemid 19170377)
6. Kaul R, McGeer A, Low DE, et al. Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiological analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med 1997;103:18. (Pubitemid 27314183)
7. Lee TC, Carrick MM, Scott BG, et al. Incidence and clinical characteristics of methicillin-resistant Staphylococcos aureus necrotizing fasciitis in a large urban hospital. Am J Surg 2007;194:809-813 (Pubitemid 350086551)
8. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005;352:1445. (Pubitemid 40471452)
9. Stephens BJ, Lathrop JC, Rice WT, Gruenberg JC. Fournier's gangrene: Historic (1764(-(1978) versus contemporary (1979-1988) differences in etiology and clinical importance. Am Surg 1993;59:149.
10. Meleney F. Hemolytic Streptococcus gangrene. Arch Surg 1924;9:317-364
11. Wong CH, Chang HC, Pasupathy S, et al. Necrotizing fasciitis: Clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 2003;85A:1454. (Pubitemid 36951128)
12. Anaya DA, McMahon K, Nathens AB, et al. Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg 2005;140:151. (Pubitemid 40229103)
13. Banwell PE, Musgrave M. Topical negative pressure therapy: Mechanisms and indications. International Wound Journal 2004;1:95-106.
14. Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared with beta lactam antibiotics treatment for invasive streptococcus pyogenes infection. Pediatr Infect Dis J 1999;18:1096-1100